Payment & Shipping Terms:
|CAS:||5708-19-0||Name:||( S ) - ( - ) - 3 - Cyclohexenecarboxylic Acid|
|Usage:||Edoxaban Intermediate||Molecular Formula:||C7H10O2|
720720 96 7,
1072 98 6
CAS No. : 5708-19-0 Edoxaban Intermediate ( S ) - ( - ) - 3 - Cyclohexenecarboxylic acid
Chemical Name : ( S ) - ( - ) - 3 - Cyclohexenecarboxylic acid
CAS No . : 5708-19-0
Molecular Formula : C7H10O2
Molecular Weight : 126.15
Usage : Edoxaban Intermediate
Description: Edoxaban is the active pharmaceutical ingredient (API) of branded drug Savaysa or Lixiana. The innovator of Edoxaban is a Japanese company called Daiichi Sankyo. Edeoxaban was approved in 2011 in Japan and by FDA in USA in 2015. Edoxaban is an anticoagulant drug for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). The patients with nonvalvular atrial fibrillation (NVAF) use it to reduce the risk of systemic embolism (SE) and stroke.
( S ) - ( - ) - 3 - Cyclohexenecarboxylic acid CAS No . : 5708-19-0 is one of its intermediates. Edoxaban is protected by some patents in some countries and areas such as USA, Europe and China. We strictly obey the laws and our product is only for R&D purpose. The buyers should determine the patent status and take the risks of patent infringement by themselves.
Competitive Advantage: Produced under cGMP conditions, support customers’ registrations.